ROLE OF PLASMA TRIGLYCERIDE IN THE REGULATION OF PLASMA LOW-DENSITY-LIPOPROTEIN (LDL) SUBFRACTIONS - RELATIVE CONTRIBUTION OF SMALL, DENSE LDL TO CORONARY HEART-DISEASE RISK

被引:450
|
作者
GRIFFIN, BA [1 ]
FREEMAN, DJ [1 ]
TAIT, GW [1 ]
THOMSON, J [1 ]
CASLAKE, MJ [1 ]
PACKARD, CJ [1 ]
SHEPHERD, J [1 ]
机构
[1] GLASGOW ROYAL INFIRM,INST BIOCHEM,GLASGOW G4 0SF,SCOTLAND
关键词
LDL SUBFRACTIONS; PLASMA TRIGLYCERIDE; CORONARY ARTERY DISEASE;
D O I
10.1016/0021-9150(94)90129-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentration of plasma LDL subfractions is described in four groups of normocholesterolaemic (total plasma cholesterol < 6.5 mmol/l) male subjects consisting of men with and without coronary artery disease (CAD+/-), as determined by angiography, post-myocardial infarct survivors (PMI) and normal, healthy controls. The CAD(+) and PMI groups were distinguished from the CAD(-) and controls by raised concentrations of plasma triglyceride, very low density lipoprotein (VLDL) cholesterol, small, dense LDL (LDL-III density (d) 1.044-1.060 g/ml) and lower concentrations of high density lipoprotein (HDL) cholesterol and large, buoyant LDL (LDL-I d 1.025-1.034 g/ml). In all groups, a subfraction of intermediate density, LDL-II (d 1.034-1.044 g/ml), was the predominant LDL species but was not related to coronary heart disease risk. Plasma triglyceride showed a positive association with LDL-II (r = 0.51, P < 0.001) below a triglyceride level of 1.5 mmol/l. Above this threshold of 1.5 mmol/l, LDL-II and LDL-I showed significant negative associations with triglyceride (LDL-II r = -0.5, P < 0.001; LDL-I r = -0.45, P < 0.001). Small, dense LDL-III showed a weak positive association with triglyceride that became highly significant above the 1.5 mmol/l threshold (r = 0.54, P < 0.001). While age was positively related to LDL-II within the control subjects (r = 0.3, P < 0.05), there was no difference in the percentage abundance or concentration of LDL-III within control and CAD(-) subjects above and below the age of 40 years. Smoking was associated with a relative deficiency of the LDL-I subfraction (LDL-I to LDL-III ratio in smokers = 0.77, in ex-smokers = 0.95, in non-smokers = 1.89; P < 0.01), as was beta-blocker medication (% LDL-I, users vs. non-users, P < 0.05). Both of these effects could be explained by their primary influence on plasma triglyceride. Analysis of the frequency distributions for the three LDL subfractions revealed the concentration of small, dense LDL-III to be bimodal around a concentration of 100 mg (lipoprotein mass)/100 mi plasma. The calculation of odds ratios based on this figure indicated relative risk estimates of 4.5 (chi(2): P < 0.01) for the presence of coronary artery disease and 6.9 (chi(2): P < 0.001) for myocardial infarction. These likelihood scores are greater than those previously described for LDL subclass pattern B as determined by gradient gel electrophoresis and, surprisingly, were maintained after correction for triglyceride, age, body mass index (BMI), smoking and drug status. The present study offers a quantitative description of LDL subfractions in clinically defined coronary artery disease and after myocardial infarction. It offers a plausible explanation for the underlying relationships between LDL subfractions and triglyceride that are operative in healthy and diseased individuals, and demonstrates the value of small, dense LDL as a predictive index of coronary risk status.
引用
收藏
页码:241 / 253
页数:13
相关论文
共 50 条
  • [41] Elevated Lipoprotein(a) Concentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease
    Afanasieva, O. I.
    Utkina, E. A.
    Artemieva, N. V.
    Ezhov, M. V.
    Adamova, I. Yu.
    Pokrovsky, S. N.
    KARDIOLOGIYA, 2016, 56 (06) : 5 - 11
  • [42] APO-B (B) AND CHOLESTEROL (C) LEVELS IN LOW-DENSITY LIPOPROTEIN (LDL) OF PATIENTS WITH CORONARY HEART-DISEASE (CHD)
    VEGA, GL
    GRUNDY, SM
    CIRCULATION, 1982, 66 (04) : 158 - 158
  • [43] VALIDITY OF THE FRIEDEWALD EQUATION FOR THE ESTIMATION OF PLASMA LOW-DENSITY-LIPOPROTEIN CHOLESTEROL (LDL-C) AT VARIOUS CONCENTRATIONS OF TRIGLYCERIDES
    KUBA, K
    FRANTZ, ID
    CLINICAL CHEMISTRY, 1987, 33 (06) : 896 - 896
  • [44] The high density lipoprotein (HDL) subfractions from patients with coronary artery disease (CAD) are less protective in preventing low density lipoprotein (LDL) subfractions from oxidation in vitro.
    Arrol, S
    Turkie, W
    Mackness, MI
    Durrington, PN
    ATHEROSCLEROSIS, 1997, 135 (01) : 14 - 14
  • [45] SERUM-CHOLESTEROL, LOW-DENSITY-LIPOPROTEIN, AND HIGH-DENSITY-LIPOPROTEIN IN CHILDREN OF FATHERS WITH PREMATURE CORONARY HEART-DISEASE
    WIDHALM, K
    PAKOSTA, R
    KERBL, B
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 623 : 469 - 471
  • [46] PLASMA HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CORONARY HEART-DISEASE IN HYPERCHOLESTEROLEMIC MEN
    GORDON, DJ
    CIRCULATION, 1985, 72 (04) : 185 - 185
  • [47] Lipoprotein subfraction changes in normal pregnancy: Threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein
    Sattar, N
    Greer, IA
    Louden, J
    Lindsay, G
    McConnell, M
    Shepherd, J
    Packard, CJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08): : 2483 - 2491
  • [48] DETECTION AND QUANTITATION OF LOW-DENSITY-LIPOPROTEIN (LDL) RECEPTORS IN HUMAN-LIVER BY LIGAND BLOTTING, IMMUNOBLOTTING, AND RADIOIMMUNOASSAY - LDL RECEPTOR PROTEIN-CONTENT IS CORRELATED WITH PLASMA LDL CHOLESTEROL CONCENTRATION
    SOUTAR, AK
    HARDERSSPENGEL, K
    WADE, DP
    KNIGHT, BL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1986, 261 (36) : 7127 - 7133
  • [49] THE ROLE OF PLASMA-LIPIDS AS PREDICTORS OF RISK FOR CORONARY HEART-DISEASE
    CASTELLI, WP
    DRUGS, 1990, 40 : 1 - 6
  • [50] Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations
    Patel, J. V.
    Caslake, M. J.
    Vyas, A.
    Cruickshank, J. K.
    Prabhakaran, D.
    Bhatnagar, D.
    Reddy, K. S.
    Lip, G. Y. H.
    Mackness, M. I.
    Hughes, E. A.
    Durrington, P. N.
    ATHEROSCLEROSIS, 2010, 209 (02) : 579 - 584